N

Neurosense Therapeutics Ltd
NASDAQ:NRSN

Watchlist Manager
Neurosense Therapeutics Ltd
NASDAQ:NRSN
Watchlist
Price: 0.769 USD 8.34% Market Closed
Market Cap: 22.8m USD

Intrinsic Value

NRSN doesn't have a meaningful market cap.

The intrinsic value of one NRSN stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.769 USD, Neurosense Therapeutics Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

NRSN Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Neurosense Therapeutics Ltd

Intrinsic Value History
Dive into the past to invest in the future

NRSN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NRSN usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NRSN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NRSN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Neurosense Therapeutics Ltd.

Explain Valuation
Compare NRSN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NRSN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neurosense Therapeutics Ltd

Current Assets 785k
Cash & Short-Term Investments 344k
Receivables 406k
Other Current Assets 35k
Non-Current Assets 199k
PP&E 176k
Other Non-Current Assets 23k
Current Liabilities 3.8m
Accounts Payable 1.4m
Other Current Liabilities 2.4m
Non-Current Liabilities 19k
Long-Term Debt 19k
Efficiency

Free Cash Flow Analysis
Neurosense Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Neurosense Therapeutics Ltd

Revenue
0 USD
Operating Expenses
-16.7m USD
Operating Income
-16.7m USD
Other Expenses
-366k USD
Net Income
-17.1m USD
Fundamental Scores

NRSN Profitability Score
Profitability Due Diligence

Neurosense Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Neurosense Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NRSN Solvency Score
Solvency Due Diligence

Neurosense Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Neurosense Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NRSN Price Targets Summary
Neurosense Therapeutics Ltd

There are no price targets for NRSN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Neurosense Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for NRSN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one NRSN stock?

The intrinsic value of one NRSN stock under the Base Case scenario is hidden USD.

Is NRSN stock undervalued or overvalued?

Compared to the current market price of 0.769 USD, Neurosense Therapeutics Ltd is hidden .

Back to Top